The Impact of Social Factors on Drug Development
Drug development exists within the context of interrelated social factors that impact its norms and practices.
Alzamend Neuro Contracts with Altasciences and iResearch Atlanta to Manage and Conduct Its Phase IIA Study in Patients with Alzheimer’s
ghp Biotechnology Awards 2022: Altasciences Named Most Innovative Global CRO/CDMO
One Integrated Solution for Meeting Your Preclinical to Clinical Drug Development Needs
Multiplexed Cytokine Comparison Across Two Species Dosed with the Same Drug
Establishment of Historical Control Reference Values of Cambodian Cynomolgus Macaque Blood Gases
Detection of Plasma Cells and their Precursors in Bone Marrow and Peripheral Blood
Evaluating Cytokine Data in Nonhuman Primate Safety Assessment Studies: A Correlation to Toxicity Outcomes
Up Close and Personal with Dr. Simone Iwabe, DVM, PhD, DACVO
Meet Dr. Simone Iwabe, DVM, PhD, DACVO
Senior Veterinary Ophthalmologist
Three Key Advantages of Conducting Early-Phase Clinical Trials in North America: An Overview of the Webinar “A Hop Across the Pond”
Regulatory processes can be challenging, and potential solutions can be found in broadening your focus to include clinical sites in the U.S. and Canada for your drug development strategy. With an understanding of how regulatory agencies and market environments may differ, you will be in a better position to optimize your program. In Altasciences’ on-demand webinar, A Hop Across the Pond, Ingrid Holmes, Vice President of Global Clinical Operations, and Dr.